The pharmacology and mechanism of action of riluzole

Neurology
A Doble

Abstract

The excitotoxic hypothesis of neurodegeneration has stimulated much interest in the possibility of using compounds that will block excitotoxic processes to treat neurologic disorders. Riluzole is a neuroprotective drug that blocks glutamatergic neurotransmission in the CNS. Riluzole inhibits the release of glutamic acid from cultured neurons, from brain slices, and from corticostriatal neurons in vivo. It is thought these effects may be partly due to inactivation of voltage-dependent sodium channels on glutamatergic nerve terminals, as well as activation of a G-protein-dependent signal transduction process. Riluzole also blocks some of the postsynaptic effects of glutamic acid by noncompetitive blockade of N-methyl-D-aspartate (NMDA) receptors. In vivo, riluzole has neuroprotective, anticonvulsant, and sedative properties. In a rodent model of transient global cerebral ischemia, a complete suppression of the ischemia-evoked surge in glutamic acid release has been observed. In vitro, riluzole protects cultured neurons from anoxic damage, from the toxic effects of glutamic-acid-uptake inhibitors, and from the toxic factor in the CSF of patients with amyotrophic lateral sclerosis.

Citations

Jan 1, 1997·Journal of Neural Transmission·J LiepertJ P Malin
Jan 1, 1999·Amino Acids·T P Obrenovitch, J Urenjak
Feb 24, 2001·Journal of Neurology·A C Ludolph
Jun 28, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Peter I JoyceAbraham Acevedo-Arozena
Jun 4, 2013·Journal of Anesthesia·Amit PrabhakarAlan David Kaye
May 5, 2012·Journal of Neural Transmission·Joanna TarasiukPiotr Lewczuk
Oct 1, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Alexei VerkhratskyJose Julio Rodriguez
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Asher B Simon, Jack M Gorman
Nov 20, 2002·Biological Psychiatry·Justine M KentJack M Gorman
Oct 3, 1998·Brain Research·P Saransaari, S S Oja
Mar 29, 2001·European Journal of Pharmacology·B MohammadiJ Bufler
Aug 7, 2002·European Journal of Pharmacology·Ying-Jun CaoKhaled M Houamed
Jun 27, 2003·European Journal of Pharmacology·Ashutosh S PariharChar-Chang Shieh
Oct 26, 2001·Journal of the Neurological Sciences·G J GroeneveldL H van den Berg
Dec 16, 1998·Journal of the Neurological Sciences·J DesaiM Swash
Aug 17, 1999·Journal of the Neurological Sciences·S KalraN R Cashman
Dec 14, 1999·Journal of the Neurological Sciences·M T DesiatoM D Caramia
Dec 14, 1999·Journal of the Neurological Sciences·Y Iwasaki, K Ikeda
Nov 30, 2002·Toxicon : Official Journal of the International Society on Toxinology·Margarete GondranAna Lúcia S Rodrigues
Feb 12, 1999·Brain Research. Brain Research Reviews·B M Morrison, J H Morrison
Aug 23, 2003·European Journal of Medicinal Chemistry·Michaela Jansen, Gerd Dannhardt
Mar 27, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Peter C Waldmeier
Jun 1, 2002·Parkinsonism & Related Disorders·J Jankovic, C Hunter
May 22, 2002·Current Opinion in Pharmacology·Karen E Morrison
Dec 4, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Brian P BrennanDost Ongür
Sep 9, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiaohua LiRichard C Shelton
Jan 12, 1999·British Journal of Pharmacology·J P HubertA Doble
Jul 25, 2000·British Journal of Pharmacology·T JehleT J Feuerstein
Oct 13, 2000·The European Journal of Neuroscience·A Urbani, O Belluzzi
Feb 4, 2009·Antioxidants & Redox Signaling·Barrie J CarterJohn F Engelhardt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.